I have been inside enough startups to know what it feels like when the work is going well and what it feels like when it isn't. When it's going well, there's a kind of forward momentum that's hard to describe to anyone who hasn't experienced it. The team is aligned. The decisions feel defensible. You can walk into a room with investors or regulators and explain your development logic without hesitation. You know where you're going and why.
When it isn't going well, there's a different feeling. A low-grade tension that doesn't go away. You're moving fast but you're not sure the foundation underneath you is solid. You're answering hard questions from your board with answers that feel slightly thinner than they should. You've built something genuinely impressive and you're starting to wonder whether the structure behind it can hold up to the scrutiny that's coming.
Most founders I work with are somewhere in that second place when we first talk. They aren't failing, and they aren't in crisis. They're just aware that something is missing, and not quite sure how to fix it without slowing everything down. That awareness is a good sign. It usually means you're paying attention to the right things.
There's a toxic idea loose in startup culture: that your only real choice is to build some magical unicorn with a billion-dollar valuation, and if you can't manage that on the first try, you should dissolve the company and accept that you failed. I reject that culture. If you've truly got something magical and the network effect is on your side, congratulations. Ride it. But not everybody has that, and not everybody has to.
You can build a great business as a solopreneur. You can build a great business with five or ten people who all get bonuses, throw a great Christmas party every year, and go home to their families with their lives intact. I love that for you. It's what I want for myself, too. A business that sustains the people who build it is a success, whether it runs a surgical robot, a software product, or a laundromat.
I love being in that moment when you've got an idea, maybe a few rough prototypes, and now you have to prove it out. You run it through the mom test. You sharpen the messaging. You put it in front of potential customers and show that this is something people truly want. Then you build the infrastructure and think hard about the box, whether it's a literal box or a metaphorical one, and what that first moment with your product will feel like for a brand-new customer.
A young product is a seedling. The work is finding it good, healthy soil, the right drainage, the right amount of sun, so the thing you believe in actually grows. Helping a founder do that is the best work I know.
You can hire people to write documents. You can hire consultants to produce deliverables. What you cannot do is hand someone else the responsibility of truly understanding your product, your customers, your market context, and your development logic, and have that understanding live somewhere useful when the diligence team or the regulator starts asking questions.
The thinking has to happen inside your team. My job is to make sure it happens correctly, in the right sequence, so the work your team produces is something they genuinely understand and can defend. That distinction matters to me. I'm not here to build something for you that you'll have to explain later. I'm here to lead your team through building something they own.
Someone who has lived inside a real program, under real investor pressure, with real consequences for getting it wrong, rather than someone who has only studied the process or advised on it from the outside.
I know what a risk framework looks like when it's built correctly and what it looks like when it isn't. I know what an FDA reviewer is actually looking for and what a diligence team will find if the structure isn't there. I know those things because I've been in those rooms for fifteen years in surgical robotics, including eight years at Galen Robotics taking the world's first cooperatively controlled microsurgical robotic assistant to FDA De Novo clearance in July 2023.
That experience is what you're getting access to when we work together. It's pattern recognition from having actually done this, not a methodology or a framework someone else developed.
This is the thing that keeps founders up at night, even if they don't say it out loud. You've built something technically impressive. You know that. Your team knows that. Your investors wrote checks because they believed it. But you also know that impressive technology and a defensible product program are not the same thing. And somewhere between the prototype and the operating room, the gap between them has to get closed.
The companies that make it are the ones that close that gap deliberately, early enough to matter, with someone who knows what closing it actually looks like. That's the work I do. And it's the work I care about.
I will tell you what I see. If the risk framework has gaps, I'll tell you. If the regulatory strategy needs rethinking, I'll tell you. If something your team has built is going to create problems at submission, I'd rather tell you now than have you discover it later.
That's not a pleasant thing to hear in the moment. But it's far better than the alternative, which is finding out when the stakes are higher and the options are fewer. The founders I work best with understand that honest feedback is a form of respect. They want to know what's actually true about their program, because they know that's the only foundation worth building on.
Hard-tech commercialization is the hardest version of the get-something-out-of-the-lab problem. Regulated products like medical devices sit at the most demanding end of it: the consequences of getting it wrong land on the patients, operators, or users who will eventually depend on what you're building, not just on the cap table.
The combination of high stakes and real difficulty is what drew me to surgical robotics fifteen years ago. The seriousness carries over no matter what you're building. A five-person software company deserves the same care as a surgical robot, and I bring it to every engagement.
If any of this resonates with where you are right now, I'd like to talk. The fastest way to start is a paid one-hour working session: $500 for an hour of my full attention on whatever you're facing, plus homework after the call and follow-up while you work through it. If it makes sense to work together longer after that, we'll talk about what that looks like.
You can book that conversation at the link below, or if you're further along, the application for the fractional engagement is there too. Either way, I'm glad you found your way here.